File Download
Supplementary
-
Citations:
- Appears in Collections:
Book Chapter: Global Governance of Anti-microbial Resistance: A Legal and Regulatory Toolkit
Title | Global Governance of Anti-microbial Resistance: A Legal and Regulatory Toolkit |
---|---|
Authors | |
Keywords | Global action plan Governance Regulation Law/legal Collective action |
Issue Date | 2020 |
Publisher | Springer |
Citation | Global Governance of Anti-microbial Resistance: A Legal and Regulatory Toolkit. In Jamrozik, E & Selgelid, M (Eds.), Ethics and Drug Resistance: Collective Responsibility for Global Public Health, p. 401-420. Cham: Springer, 2020 How to Cite? |
Abstract | Recognizing that antimicrobial resistance (AMR) poses a serious threat to global public health, the World Health Organization (WHO) has adopted a Global Action Plan (GAP) at the May 2015 World Health Assembly. Underscoring that systematic misuse and overuse of drugs in human medicine and food production is a global public health concern, the GAP-AMR urges concerted efforts across governments and private sectors, including pharmaceutical industry, medical professionals, agricultural industry, among others. The GAP has a threefold aim: (1) to ensure a continuous use of effective and safe medicines for treatment and prevention of infectious diseases; (2) to encourage a responsible use of medicines; and (3) to engage countries to develop their national actions on AMR in keeping with the recommendations. While the GAP is a necessary step to enable multilateral actions, it must be supported by effective governance in order to realize the proposed aims.
This chapter has a threefold purpose: (1) To identify regulatory principles embedded in key WHO documents relating to AMR and the GAP-AMR; (2) To consider the legal and regulatory actions or interventions that countries could use to strengthen their regulatory lever for AMR containment; and (3) To highlight the crucial role of the regulatory lever in enabling other levers under a whole-of-system approach. Effective AMR containment requires a clearer understanding of how the regulatory lever could be implemented or enabled within health systems, as well as how it underscores and interacts with other levers within a whole-of-system approach. |
Persistent Identifier | http://hdl.handle.net/10722/311795 |
ISBN | |
Series/Report no. | Public Health Ethics Analysis (PHES) ; v. 5 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ho, WLC | - |
dc.contributor.author | Lee, TL | - |
dc.date.accessioned | 2022-04-01T09:13:18Z | - |
dc.date.available | 2022-04-01T09:13:18Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Global Governance of Anti-microbial Resistance: A Legal and Regulatory Toolkit. In Jamrozik, E & Selgelid, M (Eds.), Ethics and Drug Resistance: Collective Responsibility for Global Public Health, p. 401-420. Cham: Springer, 2020 | - |
dc.identifier.isbn | 9783030278731 | - |
dc.identifier.uri | http://hdl.handle.net/10722/311795 | - |
dc.description.abstract | Recognizing that antimicrobial resistance (AMR) poses a serious threat to global public health, the World Health Organization (WHO) has adopted a Global Action Plan (GAP) at the May 2015 World Health Assembly. Underscoring that systematic misuse and overuse of drugs in human medicine and food production is a global public health concern, the GAP-AMR urges concerted efforts across governments and private sectors, including pharmaceutical industry, medical professionals, agricultural industry, among others. The GAP has a threefold aim: (1) to ensure a continuous use of effective and safe medicines for treatment and prevention of infectious diseases; (2) to encourage a responsible use of medicines; and (3) to engage countries to develop their national actions on AMR in keeping with the recommendations. While the GAP is a necessary step to enable multilateral actions, it must be supported by effective governance in order to realize the proposed aims. This chapter has a threefold purpose: (1) To identify regulatory principles embedded in key WHO documents relating to AMR and the GAP-AMR; (2) To consider the legal and regulatory actions or interventions that countries could use to strengthen their regulatory lever for AMR containment; and (3) To highlight the crucial role of the regulatory lever in enabling other levers under a whole-of-system approach. Effective AMR containment requires a clearer understanding of how the regulatory lever could be implemented or enabled within health systems, as well as how it underscores and interacts with other levers within a whole-of-system approach. | - |
dc.language | eng | - |
dc.publisher | Springer | - |
dc.relation.ispartof | Ethics and Drug Resistance: Collective Responsibility for Global Public Health | - |
dc.relation.ispartofseries | Public Health Ethics Analysis (PHES) ; v. 5 | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Global action plan | - |
dc.subject | Governance | - |
dc.subject | Regulation | - |
dc.subject | Law/legal | - |
dc.subject | Collective action | - |
dc.title | Global Governance of Anti-microbial Resistance: A Legal and Regulatory Toolkit | - |
dc.type | Book_Chapter | - |
dc.identifier.email | Ho, WLC: cwlho@hku.hk | - |
dc.identifier.authority | Ho, WLC=rp02632 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1007/978-3-030-27874-8_25 | - |
dc.identifier.hkuros | 332295 | - |
dc.identifier.spage | 401 | - |
dc.identifier.epage | 420 | - |
dc.publisher.place | Cham | - |